MedTrace Logo

Zimmer Biomet Shoulder Arthroplasty PMCF

NCT04984291 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 584

Last updated 2026-04-28

No results posted yet for this study

Summary

The objectives of this study are to confirm the safety, performance, and clinical benefits of Zimmer Biomet Shoulder Arthroplasty Systems and its instrumentation in primary or revision shoulder arthroplasty. These objectives will be assessed using standard scoring systems, radiographic evidence, and adverse event records. Safety of the system will be assessed by monitoring the frequency an incidence of adverse events.

Conditions

  • Shoulder Fractures
  • Shoulder Arthritis
  • Shoulder Osteoarthritis
  • Shoulder Deformity
  • Shoulder Injuries
  • Shoulder Pain

Interventions

DEVICE

Alliance Glenoid

Alliance Glenoid used in Primary or Revision Total Shoulder Arthroplasty

DEVICE

Identity Stem

Identity Shoulder System is intended to be used in anatomic total shoulder arthroplasty, shoulder hemi-arthroplasty, or total reverse shoulder arthroplasty in both Primary or Revision Total Shoulder Arthroplasty

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Ryan Boylan · Zimmer Biomet

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-28
Primary Completion
2033-08-15
Completion
2033-08-15
FDA Device
Yes

Countries

  • United States
  • Japan
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04984291 on ClinicalTrials.gov